A new biomarker of schizophrenia was identified in cerebral spinal fluid analysis The protein Cacna2d1 levels were reduced in schizophrenia patients causing brain circuit issues A synthetic protein SEAD1 corrected brain activity and behavior in a mouse schizophrenia model
